|
Neural stem cells derived from human embryonic stem cells carry abnormal gene expression
August 07, 2006Study may shed new light on better ways to grow potent stem cell lines
Neural stem cells grown from one of the federally approved human embryonic stem cell lines proved to be inferior to neural stem cells derived from fetal tissue donated for research, a UCLA study has found.
Researchers from the Institute for Stem Cell Biology and Medicine at UCLA coaxed cells from the federally approved line to differentiate into neural stem cells, a process that might one day be used to grow replacement cells to treat such debilitating diseases as Parkinson's and Alzheimer's. However, the neural stem cells expressed a lower level of a metabolic gene called CPT 1A, a condition that causes hypoglycemia in humans.
The study may shed new light on better ways to grow neural and other stem cells in the lab so they mirror normal cells and promote normal functioning, said Guoping Fan, an assistant professor of human genetics and a researcher in UCLA's stem cell institute. The study appears this week in an early online edition of the journal Human Molecular Genetics.
"This study is a very important first step in looking at the differentiation process in neural stem cells," said Fan, senior author of the study. "Now we have a direct measurement of the types of cells that eventually, we hope, will be used for transplantation. We can tell, are they normal or not. Understanding why these cells under-expressed CPT 1A is the first step in a comprehensive understanding of cells obtained from human embryonic stem cells."
The study, Fan said, deals with one of the most important aspects in stem cell biology-potential abnormalities in cells derived from human embryonic stem cells. Stem cells with abnormalities may not effectively treat the diseases they were created to treat, or they may result in secondary problems such as hypoglycemia, Fan said.
UCLA researchers also compared the neural stem cells they grew to cancer cells to ensure that the neural stem cells did not have any abnormalities in a DNA modification associated with gene silencing. The abnormal DNA modification is characteristically a hallmark of cancer cells. The good news, Fan said, is that the neural stem cells in their study did not share any abnormal characteristics associated with cancer. The means, theoretically, that a patient undergoing transplantation with these neural stem cells would not later develop a malignancy.
In the three-year study, researchers compared the neural stem cells grown in the lab from human embryonic stem cells to neural stem cells that already had differentiated and were derived from donated fetal tissue. The question: would the cell lines be the same and mirror the normal neural stem cells found in humans or would one cell line be superior to the other?
"Compared to the normal cells derived from the fetal tissue, the level of gene expression in the neural stem cells grown in the lab is lower," Fan said. "Proper levels of gene expression are essential for normal cell function. This study suggests that the differentiation procedure used in the lab needs to be improved so all genes are properly regulated in the stem cells we grow."
Fan and his colleagues now are studying what may have gone awry in the process they used to coax the human embryonic stem cells to differentiate into neural stem cells that may have resulted in the under-expression of the CPT 1A gene. They're also planning to repeat their work on other federally approved stem cell lines to see if the abnormality was an aberration found only in this one stem cell line. Fan and other UCLA researchers said the abnormality found in the federally approved stem cell line reinforces the need for other embryonic stem cells lines on which to conduct research.
To compare the neural stem cells, researchers extracted DNA fragments and used high throughput micro array technology to study the pattern of DNA cytosine methylation. They also monitored for levels of gene expression that are necessary for cell function as well as abnormalities that might be problematic.
"Any stem cells that might one day be used for transplantation have to be as close as possible to normal stem cells," Fan said. "The next step is to see if we can improve the way we grown these cells. I think we learned an important lesson with this study."
University of California-Los Angeles
The study may shed new light on better ways to grow neural and other stem cells in the lab so they mirror normal cells and promote normal functioning, said Guoping Fan, an assistant professor of human genetics and a researcher in UCLA's stem cell institute. The study appears this week in an early online edition of the journal Human Molecular Genetics.
"This study is a very important first step in looking at the differentiation process in neural stem cells," said Fan, senior author of the study. "Now we have a direct measurement of the types of cells that eventually, we hope, will be used for transplantation. We can tell, are they normal or not. Understanding why these cells under-expressed CPT 1A is the first step in a comprehensive understanding of cells obtained from human embryonic stem cells."
The study, Fan said, deals with one of the most important aspects in stem cell biology-potential abnormalities in cells derived from human embryonic stem cells. Stem cells with abnormalities may not effectively treat the diseases they were created to treat, or they may result in secondary problems such as hypoglycemia, Fan said.
UCLA researchers also compared the neural stem cells they grew to cancer cells to ensure that the neural stem cells did not have any abnormalities in a DNA modification associated with gene silencing. The abnormal DNA modification is characteristically a hallmark of cancer cells. The good news, Fan said, is that the neural stem cells in their study did not share any abnormal characteristics associated with cancer. The means, theoretically, that a patient undergoing transplantation with these neural stem cells would not later develop a malignancy.
In the three-year study, researchers compared the neural stem cells grown in the lab from human embryonic stem cells to neural stem cells that already had differentiated and were derived from donated fetal tissue. The question: would the cell lines be the same and mirror the normal neural stem cells found in humans or would one cell line be superior to the other?
"Compared to the normal cells derived from the fetal tissue, the level of gene expression in the neural stem cells grown in the lab is lower," Fan said. "Proper levels of gene expression are essential for normal cell function. This study suggests that the differentiation procedure used in the lab needs to be improved so all genes are properly regulated in the stem cells we grow."
Fan and his colleagues now are studying what may have gone awry in the process they used to coax the human embryonic stem cells to differentiate into neural stem cells that may have resulted in the under-expression of the CPT 1A gene. They're also planning to repeat their work on other federally approved stem cell lines to see if the abnormality was an aberration found only in this one stem cell line. Fan and other UCLA researchers said the abnormality found in the federally approved stem cell line reinforces the need for other embryonic stem cells lines on which to conduct research.
To compare the neural stem cells, researchers extracted DNA fragments and used high throughput micro array technology to study the pattern of DNA cytosine methylation. They also monitored for levels of gene expression that are necessary for cell function as well as abnormalities that might be problematic.
"Any stem cells that might one day be used for transplantation have to be as close as possible to normal stem cells," Fan said. "The next step is to see if we can improve the way we grown these cells. I think we learned an important lesson with this study."
University of California-Los Angeles
Neural Stem Cells News and Current Neural Stem Cells Events RSSMIT identifies cells for spinal-cord repair
A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
UNC study ties ending moderate drinking to depression
Scientific evidence has long suggested that moderate drinking offers some protection against heart disease, certain types of stroke and some forms of cancer.
Researchers link early stem cell mutation to autism
In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism.
Scientists Find Stem Cells For the First Time in the Pituitary
A team of researchers led by scientists at Cold Spring Harbor Laboratory have for the first time identified stem cells that allow the pituitary glands of mice to grow even after birth.
Scientists ask whether microscaffolding can help stem cells rebuild brain after stroke damage
Inserting tiny scaffolding into the brain could dramatically reduce damage caused by strokes the UK National Stem Cell Network Annual Science Meeting will hear today (10 April).
Protein protects embryonic stem cells' versatility and self-renewal
A protein known as REST blocks the expression of a microRNA that prevents embryonic stem cells from reproducing themselves and causes them to differentiate into specific cell types, scientists at The University of Texas M. D. Anderson Cancer Center report in the journal Nature.
Post brain injury: New nerve cells originate from neural stem cells
Most cells in the human brain are not nerve cells, but supporting cells (glial cells). They serve as a framework for nerve cells and play an important role in the wound reaction that occurs with injuries to the brain.
Building brains: Mammalian-like neurogenesis in fruit flies
A new way of generating brain cells has been uncovered in Drosophila. The findings, published this week in the online open access journal Neural Development, reveal that this novel mode of neurogenesis is very similar to that seen in mammalian brains, suggesting that key aspects of neural development could be shared by insects and mammals.
Stem cell research aims to tackle Parkinson's disease
Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson's disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.
Brain stem cells sensitive to space radiation
Cold Spring Harbor Laboratory (CSHL) scientists recently led a team of researchers to study potential effects of space radiation on astronauts.
More Neural Stem Cells News Articles
| © 2008 BrightSurf.com |